Skip to content Skip to left sidebar Skip to footer

Meaningful Use (HL7)

PhilaVax supports eligible clinics and hospitals that wish to submit immunization data via Health Level 7 (HL7). This process allows for more timely and accurate immunization reporting compared to manual logs or monthly flat files. On this page:

PhilaVax supports HL7 v2.5.1 reporting via batch, real-time and bidirectional messages. Starting in 2018, PhilaVax will conform to the CDC HL7 2.5.1 Implementation Guide for Immunization Messaging, Release 1.5 and Addendum, including supporting Query/Response, acknowledgement messaging, and the receipt of National Drug Codes (NDC) for newly-administered immunizations.

Meaningful Use

In July 2010, the Centers for Medicaid and Medicare Services final rule on the Electronic Health Record Incentive Program defined measures for eligible professionals and hospitals in order to receive incentive payment. Submission of immunization data to an immunization registry meets one of the public health objectives.

To qualify for Stage 2, successfully enroll and work towards ongoing submission of electronic immunization data via an HL7 interface during the EHR reporting period.

Enrolling in PhilaVax HL7

If you are a health care provider who wants to report immunization data to PhilaVax using HL7, start the process by filling out the  PhilaVax Clinic-Health System Enrollment Form.

Once enrolled, we’ll need to test data transmission. To do this, you’ll need to fill out the PhilaVax Entity Confidentiality Agreement.


Meaningful Use

HL7 testing guides

Other resources
To learn more about the Electronic Health Records Incentive Program – CMS EHR Incentive Overview

Online tool to help test if your practice or hospital would successfully demonstrate meaningful use – CMS Meaningful Use Attestation Calculator

CDC Standard Code Set – HL7 Table 0292 Vaccine Administered (CVX)